Stock data
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB) reported revenue of US$201.49M and net income of -US$66.54M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$201.49M | US$104.46M | -US$40.38M | -US$66.54M | — |
| 2024 | US$200.45M | US$111.11M | -US$20.52M | -US$6.02M | — |
| 2023 | US$193.01M | US$109.43M | -US$27.84M | -US$12.15M | — |
| 2022 | US$164.04M | US$100.97M | -US$1.80M | US$2.48M | — |
| 2021 | US$127.95M | US$79.14M | US$9.16M | US$3.03M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$48.14M | -US$12.16M | — |
| 2026-03-31 | US$44.13M | -US$18.87M | — |
| 2025-12-31 | US$62.14M | -US$44.08M | — |
| 2025-09-30 | US$52.29M | -US$5.48M | — |
| 2025-06-30 | US$45.60M | -US$5.58M | — |
| 2025-03-31 | US$41.46M | -US$11.40M | — |
| 2024-12-31 | US$57.48M | US$9.64M | — |
| 2024-09-30 | US$51.50M | US$0.94M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.